Comparison
2q13 Microdeletion Syndrome C6012360 vs 12p12 1 Microdeletion Syndrome C4755260
Clinical comparison between 2q13 Microdeletion Syndrome and 12p12 1 Microdeletion Syndrome for differential diagnosis and treatment planning.
2q13 Microdeletion Syndrome C6012360
A rare genetic condition where a small piece of chromosome 2 is missing. It can affect development and cause distinctive features. Care involves multiple specialists based on symptoms.
12p12 1 Microdeletion Syndrome C4755260
A rare chromosomal condition involving a small missing piece of chromosome 12. Features vary but may include developmental delays and congenital differences. Care involves monitoring and supportive interventions.
6 comparison axes
Onset
2q13 Microdeletion Syndrome C6012360
Variable
12p12 1 Microdeletion Syndrome C4755260
0-null
Onset patterns differ
Severity
2q13 Microdeletion Syndrome C6012360
severe
12p12 1 Microdeletion Syndrome C4755260
moderate
Different severity levels
Chronic
2q13 Microdeletion Syndrome C6012360
Chronic
12p12 1 Microdeletion Syndrome C4755260
Chronic
Differing course
Communicable
2q13 Microdeletion Syndrome C6012360
No
12p12 1 Microdeletion Syndrome C4755260
No
Different transmission
Body System
2q13 Microdeletion Syndrome C6012360
congenital
12p12 1 Microdeletion Syndrome C4755260
congenital
Same/different system
Category
2q13 Microdeletion Syndrome C6012360
rare-disease
12p12 1 Microdeletion Syndrome C4755260
genetic
Different category
Bottom line
2q13-microdeletion-syndrome-C6012360 and 12p12-1-microdeletion-syndrome-C4755260 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2q13 Microdeletion Syndrome C6012360 | 12p12 1 Microdeletion Syndrome C4755260 | Discriminating power |
|---|---|---|---|
| Developmental differences | May affect development; severity described as severe, but exact pattern is not established. | May include developmental delay; severity described as moderate and variable. | Low |
| Congenital physical differences | Distinctive features are possible, but which features are not specified. | Congenital differences may occur and vary among individuals. | Low |
| Age at recognition | Onset is described as variable. | Onset is not established in the supplied data. | Low |
When to favor each condition
Choose 2q13 Microdeletion Syndrome C6012360 when
Chromosomal testing identifies a 2q13 microdeletion
The diagnosis depends on the deleted chromosomal region, not symptoms alone.
High
Clinician documents a severe congenital presentation
Severity is labeled severe, but this does not prove the diagnosis without genetics.
Low
Care planning for a confirmed 2q13 finding
Support should follow the person's actual symptoms and specialist needs.
Moderate
Choose 12p12 1 Microdeletion Syndrome C4755260 when
Testing identifies a 12p12.1 microdeletion
The chromosomal location distinguishes it from a 2q13 deletion.
High
Features are variable with moderate severity
This matches the supplied severity label but is not diagnostic alone.
Low
Monitoring and supportive care are the main needs
The source emphasizes monitoring and supportive interventions.
Moderate
How key tests differ
| Test | 2q13 Microdeletion Syndrome C6012360 | 12p12 1 Microdeletion Syndrome C4755260 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May detect a small missing segment at 2q13. | May detect a small missing segment at 12p12.1. | The reported locus distinguishes the conditions; clinician and laboratory confirmation is required. |
| Clinical genetics evaluation | Assesses development and congenital features without a fixed pattern here. | Assesses variable developmental and congenital findings. | Examination supports care but cannot replace chromosomal testing. |
| Symptom-directed investigations | Chosen according to individual findings; no standard cutoff is established. | Chosen according to individual findings; no standard cutoff is established. | Abnormal results are findings, not diagnoses, and need clinical interpretation. |
Prognosis comparison
2q13 Microdeletion Syndrome C6012360
- Outcome
- Long-term outcome is not established; the source labels severity as severe.
- Factors
- Actual developmental, congenital, and medical findings.
12p12 1 Microdeletion Syndrome C4755260
- Outcome
- Long-term outcome is not established; severity is labeled moderate and variable.
- Factors
- Range and severity of developmental and congenital differences.
Time frame: Chronic course; precise milestones or survival data are not supplied.
Confirmed locus, individual symptoms, and access to supportive care.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental support needs | Potentially substantial given the severe label, but extent is not established. May occur with variable developmental delay. Needs should be assessed individually rather than assumed. |
| Congenital organ or structural differences | Possible but unspecified in the source. Possible and described as variable. Targeted evaluation depends on clinical findings. |
| Long-term multispecialty care | Care may involve multiple specialists based on symptoms. Care emphasizes monitoring and supportive interventions. Neither condition is communicable; both are described as chronic. |
Patient education highlights
- HighDiagnosis
A chromosomal test result identifies the deletion; symptoms alone do not establish which syndrome is present.
- HighIndividual variation
Features and severity can vary, and many specific outcomes are not established from these data.
- MediumCare
Follow-up is individualized, supportive, and coordinated by clinicians familiar with the confirmed finding.